Zymar (Gatifloxacin ophthalmic solution, 0.3%)

News
Article

Fluoroquinolone approved for bacterial conjunctivitis

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Logan Lutton
August 13th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
August 13th 2025
Podcast

Listen

Preserving the History of Retina, One Narrative at a Time

Preserving the History of Retina, One Narrative at a Time

Denise Myshko
August 13th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 13th 2025
Podcast

Listen

ZAKARIYAE-stock@adobe.com

FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor

Denise Myshko
August 13th 2025
Article

Read More

kitsawet-stock@adobe.com

Valneva Updates Safety Label of Chikungunya Virus Vaccine

Denise Myshko
August 13th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.